Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Medcomm|August 5, 2025
RNA Epigenetics in Cancer: Current Knowledge and Therapeutic ImplicationsShanhe Huang, Zonglin Li, Weilong Lin, et al.
The American Journal of Case Reports|June 7, 2025
Efficacy of Hepatic Artery Infusion Chemotherapy with Bevacizumab and Sintilimab in Advanced Hepatocellular Carcinoma: A Case ReportChenguang Hua, Shanhe Huang, Bo Ding, et al.
BMC Nephrology|May 2, 2024
Association between serum sodium trajectory and mortality in patients with acute kidney injury: a retrospective cohort studyShanhe Huang, Xiaojing Li, Baorong Chen, et al.
Critical Reviews in Oncology/Hematology|May 30, 2025
Advances in improving the efficacy of anti-PD-1/PD-L1 therapy in intrahepatic cholangiocarcinomaShanhe Huang, Chenguang Hua, Bo Ding, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|April 9, 2026
Mapping the immune landscape of PCa: From tumor microenvironment to therapeuticsShanhe Huang, Yuan Ou, Wei Zhuang, et al.
International Journal of Biological Macromolecules|February 24, 2026
From clinical evidence to biological mechanisms: GPRC5B as a key mediator of metabolic syndrome-associated prostate cancerWeilong Lin, Peixian Chen, Yuan Ou, et al.
International Journal of Biological Sciences|September 23, 2024
Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancerBingheng Li, Bisheng Cheng, Hao Huang, et al.
Oral Oncology|September 2, 2025
Developing a predictive nomogram model for incidence of adverse outcomes in oral and maxillofacial tumor patients undergoing free flap reconstructionJianwei Lin, Zeyu Liu, Yuetao Zheng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 16, 2026
ANXA2-mediated Phagocytosis Generates AR+ Macrophages to Confer Enzalutamide Resistance in Prostate CancerYong Luo, Tianlong Luo, Lingfeng Li, et al.
Pageof 1